Visualant Enters $10 Million Qualcomm Tricorder XPRIZE Competition to leverage technology innovation in areas such as artificial intelligence and wireless sensing SEATTLE, Wash., June 10, 2013 (GLOBE NEWSWIRE) -- via PRWEB - Visualant, Inc. (OTCBB:VSUL) – an industry-leading provider of chromatic-based identification and diagnostic solutions with its ChromaID™ technology, announced today it is entering into the Qualcomm Tricorder XPRIZE, a global competition to revolutionize healthcare. In this competition, teams will leverage technology innovation in areas such as artificial intelligence and wireless sensing – much like the medical Tricorder of Star Trek® fame – to make medical diagnoses independent of a physician or healthcare provider. The goal of the competition is to drive development of devices that will give consumers access to their state of health in the palm of their hand. Professor Tom Furness (Chairman of the Visualant's Scientific Advisory Board) is leading a team of students and researchers applying Visualant's ChromaID technology to health sensing opportunities. Professor Furness has considerable experience in the development of sensing technologies, having received the 2001 Satava Award (with the University of Washington HIT Lab) for advances in medical technology and in 1998 the Discover Award for Technological Innovation for his ground-breaking Virtual Retinal Display technology. "The Qualcomm Tricorder XPRIZE provides a great catalyst for our research team to apply our ChromaID technology to enhance mobile healthcare devices", said Ron Erickson, President and CEO of Visualant. "We are also excited about the potential to collaborate with other teams through the framework provided by the XPRIZE organization." The Qualcomm Tricorder XPRIZE is a $10 million global competition to stimulate innovation and integration of precision diagnostic technologies, making reliable health diagnoses available directly to "health consumers" in their homes. For more information about team Visualant, please visit http://www.visualant.net. About Visualant, Inc. Visualant™ is a public company whose shares trade under the stock symbol, VSUL. The Visualant Spectral Pattern Matching™ technology directs structured light onto a substance, through a liquid/gas, or off a surface, to capture a unique ChromaID™. When matched against existing databases, a ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab–based tests. Visualant entered into a one year Joint Development Agreement on May 31, 2012 with Sumitomo Precision Products Co., Ltd. ("SPP"), which focuses on the commercialization of the SPM technology and a License Agreement providing SPP with an exclusive license of the SPM technology in identified Asian territories. For more information, visit http://www.visualant.net. Sumitomo Precision Products Co., Ltd. Is publicly traded and has operations in Japan, United States, China, United Kingdom, Canada, and other parts of the world. Additional information on SPP is available at http://www.spp.co.jp/English/index2-e.html. Press contacts: Hal Bringman hal(at)nvpr(dot)com +1 (206) 299-0622 ext 801 +1 (310) 210-8011 Skype halbringman Tina Qunell tina(at)nvpr(dot)com +1 (206) 919-9652 This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2013/6/prweb10816226.htm CONTACT: NVPR Hal Bringman firstname.lastname@example.org (323) 851-6877
Visualant Enters $10 Million Qualcomm Tricorder XPRIZE
Press spacebar to pause and continue. Press esc to stop.